Monday, March 03, 2025 | 01:03 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Aarti Drugs nears 5-year high; stock rallies 26% in 5 days in a weak market

Analysts believe the firm's API business will continue its growth momentum driven by capacity expansion and gain in market share in existing products

Aarti Drugs nears 5-year high; stock rallies 26% in 5-days in weak market
Premium

SI Reporter Mumbai
Shares of Aarti Drugs rallied 9 per cent to near five-year high of Rs 813 on the BSE on Thursday in an otherwise weak market on expectation of strong volume growth to continue and reflect in revenue and earnings.

The pharmaceutical firm's stock was trading at its highest level since April 15, 2015. In the past five days, the stock has surged 26 per cent, as compared to 4.4 per cent decline in the benchmark S&P BSE Sensex. The stock hit an all-time high of Rs 874 in April 2015.

In the October-December 2019 (Q3FY20) quarter, Aarti Drugs

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in